期刊文献+

关于限制使用医疗技术临床准入的伦理缺失分析 被引量:4

Analysis of Ethical Absence of Clinical Admission Assessment on the Limitative Medical Technologies
下载PDF
导出
摘要 限制使用医疗技术临床准入是医疗技术准入制度的重点内容。然而,目前我国对限制使用技术的准入研究较为滞后,特别是对其伦理评估研究更是缺乏。从伦理审查的认识缺位,评估主体及其伦理素养缺位,评估标准缺失及缺乏全过程评估等四方面对目前我国限制使用医疗技术临床准入伦理缺失的危害性进行分析,并呼吁尽快制定科学、合理、符合我国实际的伦理评估指标体系。 Clinical admission assessment on the limitative medical technologies is important content of med - tech admission system. However, current relevant research in China is quite backward, especially those on the ethical assessment research on clinical admission of the limitative medical technologies, which is even vacant at all. The article will analyze the harm of recent ethical absence of clinical admission on the limitative medical technologies from four aspects, including the recognition absence of ethical review, the absence of assessment subjects and their ethical cultivation, the absence of assessment standard, and the absence of a whole - range assessment. It is concluded that a scientific, reasonable, and realistic indexing system of the ethical assessment for clinical admission of the limitative medical technologies is also urgently called for.
作者 陈康 黄钢
出处 《中国医学伦理学》 2009年第3期14-16,共3页 Chinese Medical Ethics
基金 广东省软科学研究计划项目基金"广东省限制使用医疗技术临床准入的伦理评估研究" 项目编号:2006B70102003
关键词 医疗技术 临床准入 伦理缺失 Medical Technology Clinical Admission Ethical Absence
  • 相关文献

参考文献2

二级参考文献6

共引文献46

同被引文献47

  • 1徐宗良.我国人体临床试验和研究中有关伦理审查的若干问题[J].医学与哲学,2005,26(5):29-30. 被引量:24
  • 2王岳.医务人员履行告知有新要求[N].健康报,2009-12-29(6). 被引量:2
  • 3Jhala A,Mistry M.Endoscopic lumbar discetomy:Experience of first 100 cases[J].Indian J Orthop,2010,44(2):184-190. 被引量:1
  • 4Matsumoto M,Hasegawa T,Ito M,et al.Incidence of complications associated with spinal endoscopic surgery:nationwide survey in 2007 by the Committee on Spinal Endoscopic Surgical Skill Qualification of Japanese Orthopaedic Association[J].J Orthop Sci,2010,15(1):92-96. 被引量:1
  • 5国家食品药品监督管理局.药物临床试验伦理审查工作指导原则(2010年)[EB/OL].(2010-11-2)[2011-01-21].http://www.sfda.gov.cn/WS01/CL0058/55613.html. 被引量:2
  • 6Saarni S I, Hofmann B* Lampe K,et al. Ethical analysis to improvedecision-making on health technologies [J]. Bull World Health Organ,2008,86(8):617-623. 被引量:1
  • 7Boulkedid R, Abdoul H, Loustau M,et al. Using and Reporting the DelphiMethod for Selecting Healthcare Quality Indicators . A Systematic Review[J]. PLoS ONE,2011,6(6) :e20476. 被引量:1
  • 8Geisser M E, Alschuler K N.Hutchinson R. A Delphi Study to EstablishImportant Aspects of Ethics Review[J]. J Empir Res Hum Res Ethics,2011,6(l):21 - 24. 被引量:1
  • 9Prinsen C A C,Vohra S,Rose M R,et al. Core Outcome Measures inEffectiveness Trials (COMET) initiative : protocol for an internationalDelphi study to achieve consensus on how to select outcome measurementinstruments for outcomes included in a 4 core outcome set,[J]. Trials,2014,15:247. 被引量:1
  • 10Kingsford C, Salzberg S L. What are decision trees?[J]. Nat Biotechnol.2008,26(9):1011 - 1013. 被引量:1

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部